Nisa Investment Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.1K | Sell |
6,939
-357
| -5% | -$2.89K | ﹤0.01% | 1558 |
|
2025
Q1 | $61.1K | Buy |
7,296
+39
| +0.5% | +$327 | ﹤0.01% | 1544 |
|
2024
Q4 | $57.5K | Buy |
7,257
+188
| +3% | +$1.49K | ﹤0.01% | 1647 |
|
2024
Q3 | $58.8K | Sell |
7,069
-221,848
| -97% | -$1.85M | ﹤0.01% | 1604 |
|
2024
Q2 | $1.45M | Buy |
228,917
+222,144
| +3,280% | +$1.41M | 0.01% | 780 |
|
2024
Q1 | $41K | Buy |
6,773
+73
| +1% | +$442 | ﹤0.01% | 1703 |
|
2023
Q4 | $40.7K | Hold |
6,700
| – | – | ﹤0.01% | 1687 |
|
2023
Q3 | $28.3K | Hold |
6,700
| – | – | ﹤0.01% | 1903 |
|
2023
Q2 | $20.8K | Buy |
6,700
+5,180
| +341% | +$16.1K | ﹤0.01% | 2089 |
|
2023
Q1 | $2K | Hold |
1,520
| – | – | ﹤0.01% | 2310 |
|
2022
Q4 | $3K | Hold |
1,520
| – | – | ﹤0.01% | 2326 |
|
2022
Q3 | $3K | Hold |
1,520
| – | – | ﹤0.01% | 2332 |
|
2022
Q2 | $5K | Hold |
1,520
| – | – | ﹤0.01% | 2265 |
|
2022
Q1 | $6K | Sell |
1,520
-630
| -29% | -$2.49K | ﹤0.01% | 2275 |
|
2021
Q4 | $10K | Hold |
2,150
| – | – | ﹤0.01% | 2025 |
|
2021
Q3 | $11 | Hold |
2,150
| – | – | ﹤0.01% | 2190 |
|
2021
Q2 | $11 | Sell |
2,150
-17,900
| -89% | -$92 | ﹤0.01% | 2213 |
|
2021
Q1 | $135 | Hold |
20,050
| – | – | ﹤0.01% | 1625 |
|
2020
Q4 | $92K | Buy |
20,050
+1,150
| +6% | +$5.28K | ﹤0.01% | 1766 |
|
2020
Q3 | $73K | Hold |
18,900
| – | – | ﹤0.01% | 1649 |
|
2020
Q2 | $90K | Sell |
18,900
-11,800
| -38% | -$56.2K | ﹤0.01% | 1466 |
|
2020
Q1 | $107K | Buy |
30,700
+30,375
| +9,346% | +$106K | ﹤0.01% | 1351 |
|
2019
Q4 | $2K | Sell |
325
-39,120
| -99% | -$241K | ﹤0.01% | 1987 |
|
2019
Q3 | $114K | Buy |
39,445
+39,120
| +12,037% | +$113K | ﹤0.01% | 1431 |
|
2019
Q2 | $2K | Hold |
325
| – | – | ﹤0.01% | 1971 |
|
2019
Q1 | $5K | Sell |
325
-15,382
| -98% | -$237K | ﹤0.01% | 1897 |
|
2018
Q4 | $213K | Hold |
15,707
| – | – | ﹤0.01% | 1225 |
|
2018
Q3 | $349K | Buy |
15,707
+15,382
| +4,733% | +$342K | ﹤0.01% | 1196 |
|
2018
Q2 | $5K | Buy |
+325
| New | +$5K | ﹤0.01% | 1829 |
|